article thumbnail

22q11.2 Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030 – ResearchAndMarkets.com

Cannabis Law Report

Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.

article thumbnail

Americans Will Cultivate Over 4 Billion Grams Of Homegrown Cannabis in 2022

Veriheal

According the market researcher’s projection, the industry is expected to achieve a value of $4 billion by 2030. It also may be more convenient to grow cannabis at home if a consumer lives in a rural area or in a state that only has a limited number of accessible dispensaries. Why Are People Growing Cannabis at Home?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing

Cannabis Law Report

On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. . trillion by 2030.

article thumbnail

How Medical Cannabis can unlock a higher quality of life for seniors

MGC Pharma

According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. Unfortunately, the regulatory process is fraught with bottlenecks, with no more than 500 Australians having legal access to Medical Cannabis.

article thumbnail

Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing

Cannabis Law Report

June 18, 2021 (Chicago) — Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences ’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering.

article thumbnail

Switzerland Just Got One Step Closer to Federally Legalizing Weed

SpeedWeed

In exchange for access to legal pot, each participant has agreed to have their health regularly monitored for the duration of the study. Lawmakers also gave themselves an option to extend the program even longer, so the final debate over legalization could actually be put off until 2030.

article thumbnail

Trouble Brewing? A Look at the Cannabis Industry’s Signs of Distress – and Resilience

Cannabis Law Report

One theory is that many investors in publicly traded MSOs speculated that by now, Congress would have at least passed a bill to decriminalize the plant or would have passed the SAFE Banking Act to ease cannabis businesses’ access to banking services. According to that same study, annual legal sales of cannabis in the U.S. billion by 2025.